Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma

Surgery Today

Volumn 40, Issue 1, 2010, Pages 46-53

  Toiyama, Yuji ^a   Miki, Chikao ^a   Inoue, Yasuhiro ^a   Minobe, Sayaka ^b   Urano, Hiroko ^b   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Curative intent; Interleukin 10; Prognostic factor

Indexed keywords

INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; COLORECTAL CARCINOMA; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTESTINAL MUCOSA; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 76849084918     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-009-4016-7     Document Type: Article

References (48)

1. G. Pawelec Y. Barnett R. Forsey D. Frasca A. Globerson J. McLeod, et al. 2002 T cells and aging, January 2002 update Front Biosci 7 1056 1183
2. C. Grunfeld 2002 Leptin and the immunosuppression of malnutrition J Clin Endocrinol Metab 87 3038 3039 10.1210/jc.87.7.3038 1:CAS:528: DC%2BD38XlsVGjsbY%3D 12107197 (Pubitemid 34816341)
3. C. Miki K. Tanaka Y. Inoue T. Araki M. Ohi Y. Mohri, et al. 2008 Perioperative host-tumor inflammatory interactions: a potential trigger for disease recurrence following a curative resection for colorectal cancer Surg Today 38 579 584 10.1007/s00595-007-3674-6 18612780 (Pubitemid 351977650)
4. A.G. Heriot J.B. Marriott S. Cookson D. Kumar A.G. Dalgleish 2000 Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection Br J Cancer 82 1009 1012 10.1054/bjoc.1999.1034 1:CAS:528:DC%2BD3cXitVClsrw%3D 10737381
5. G. Galizia E. Lieto F. De Vita C. Romano M. Orditura P. Castellano, et al. 2002 Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome J Interferon Cytokine Res 22 473 482 10.1089/10799900252952262 1:CAS:528:DC%2BD38XjvFShtr0%3D 12034030 (Pubitemid 34579550)
6. W. Zou 2005 Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat Rev Cancer 5 263 274 10.1038/nrc1586 1:CAS:528:DC%2BD2MXivVars7g%3D 15776005 (Pubitemid 40488632)
7. R. de Waal Malefyt J. Haanen H. Spits M.G. Roncarolo A. te Velde C. Figdor, et al. 1991 Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression J Exp Med 174 915 924 10.1084/jem.174.4. 915 1655948
8. K. Taga H. Mostowski G. Tosato 1993 Human interleukin-10 can directly inhibit T cell growth Blood 81 2964 2971 1:CAS:528:DyaK3sXkvFegtL4%3D 8499633
9. P. Ralph I. Nakoinz A. Sampson-Johannes S. Fong D. Lowe H.Y. Min, et al. 1992 IL-10, T-lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor J Immunol 148 808 814 1:CAS:528:DyaK38Xht1Kmu70%3D 1730874
10. K. Avradopoulos S. Mehta D. Blackinton H.J. Wanebo 1997 Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck Ann Surg Oncol 4 184 190 10.1007/BF02303803 1:STN:280:DyaK2s3jvFWluw%3D%3D 9084857
11. B. Sredni M. Weil G. Khomenok I. Lebenthal S. Teitz Y. Mardor, et al. 2004 Ammonium trichloro(dioxoethylene-o,o′)tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop Cancer Res 64 1843 1852 10.1158/0008-5472.CAN-03-3179 1:CAS:528: DC%2BD2cXhslersro%3D 14996748 (Pubitemid 38428710)
12. S. Alas C. Emmanouilides B. Bonavida 2001 Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis Clin Cancer Res 7 709 723 1:CAS:528:DC%2BD3MXjtVOnsr0%3D 11297268
13. J. Nemunaitis T. Fong P. Shabe D. Martineau D. Ando 2001 Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma Cancer Invest 19 239 247 10.1081/CNV-100102550 1:STN:280:DC%2BD3M3mt1OgsA%3D%3D 11338880 (Pubitemid 32374364)
14. J. Kim R.L. Modlin R.L. Moy S.M. Dubinett T. McHugh B.J. Nickoloff, et al. 1995 IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response J Immunol 155 2240 2247 1:CAS:528:DyaK2MXnsVShsLo%3D 7636270
15. F. Wittke R. Hoffmann J. Buer I. Dallmann K. Oevermann S. Sel, et al. 1999 Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma Br J Cancer 79 1182 1184 10.1038/sj.bjc.6690189 1:STN:280:DyaK1M7ps1eqsA%3D%3D 10098756 (Pubitemid 29087895)
16. G.A. Gastl J.S. Abrams D.M. Nanus R. Oosterkamp J. Silver F. Liu, et al. 1993 Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression Int J Cancer 55 96 101 10.1002/ijc.2910550118 1:CAS:528:DyaK2cXhs1Shsbc%3D 8344757
17. J.P. Herbeuval E. Lelievre C. Lambert M. Dy C. Genin 2004 Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage derived IL-6 J Immunol 172 4630 4636 1:CAS:528:DC%2BD2cXitlOqur8%3D 15034082
18. H. Bohlen M. Kessler M. Sextro V. Diehl H. Tesch 2000 Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease Ann Hematol 79 110 113 10.1007/s002770050564 1:CAS:528: DC%2BD3cXhvFClsbk%3D 10803931
19. E. Lech-Maranda L. Baseggio J. Bienvenu C. Charlot F. Berger D. Rigal, et al. 2004 Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma Blood 103 3529 3534 10.1182/blood-2003-06-1850 1:CAS:528:DC%2BD2cXjslKgtLw%3D 14701701 (Pubitemid 38525688)
20. G.Y. Chau C.W. Wu W.Y. Lui T.J. Chang H.L. Kao L.H. Wu, et al. 2000 Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma Ann Surg 231 552 558 10.1097/00000658-200004000-00015 1:STN:280:DC%2BD3c3htlahsw%3D%3D 10749617 (Pubitemid 30185863)
21. K. Asadullah W. Sterry H.D. Volk 2003 Interleukin-10 therapy - review of a new approach Pharmacol Rev 55 241 269 10.1124/pr.55.2.4 1:CAS:528: DC%2BD3sXltVSgtbk%3D 12773629 (Pubitemid 36666048)
22. B. Ebrahimi S.L. Tucker D. Li J.L. Abbruzzese R. Kurzrock 2004 Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis Cancer 101 2727 2736 10.1002/cncr.20672 1:CAS:528: DC%2BD2MXivFOhtw%3D%3D 15526319 (Pubitemid 39603180)
23. S. Negrier D. Perol C. Menetrier-Caux B. Escudier M. Pallardy A. Ravaud, et al. 2004 Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6 - from the Groupe Francais d'Immunotherapie J Clin Oncol 22 2371 2378 10.1200/JCO.2004.06.121 1:CAS:528:DC%2BD2cXpsVWlurg%3D 15197198 (Pubitemid 41115394)
24. C. Lu J.C. Soria X. Tang X.C. Xu L. Wang L. Mao, et al. 2004 Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers J Clin Oncol 22 4575 4583 10.1200/JCO.2004.01.091 15542809 (Pubitemid 41185125)
25. W. Dummer J.C. Becker A. Schwaaf M. Leverkus T. Moll E.B. Brocker 1995 Elevated serum levels of Interleukin-10 in patients with metastatic malignant melanoma Melanoma Res 5 67 68 10.1097/00008390-199502000-00008 1:STN:280:DyaK2M3lt1yitg%3D%3D 7734958
26. W.H. Gotlieb J.S. Abrams J.M. Watson T.J. Velu J.S. Berek O. Martinez-Maza 1992 Presence of Interleukin-10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers Cytokine 4 385 390 10.1016/1043-4666(92)90082-3 1:CAS:528:DyaK3sXmt1eqtb0%3D 1421000
27. V.P. Khatri M.A. Caligiuri 1998 A review of the association between Interleukin-10 and human B-cell malignancies Cancer Immunol Immunother 46 239 244 10.1007/s002620050483 1:CAS:528:DyaK1cXmt1ertL8%3D 9690451 (Pubitemid 28332921)
28. B. Klein Z.Y. Lu Z.J. Gu V. Costes M. Jourdan J.F. Rossi 1999 Interleukin-10 and Gp130 cytokines in human multiple myeloma Leuk Lymphoma 34 63 70 1:CAS:528:DC%2BD3cXlsFSks7g%3D 10350333
29. F. De Vita M. Orditura G. Galizia C. Romano A. Roscigno E. Lieto, et al. 2000 Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients Chest 117 365 373 10.1378/chest.117.2.365 10669676
30. F. De Vita M. Orditura G. Galizia C. Romano S. Infusino A. Auriemma, et al. 1999 Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies Cancer 86 1936 1943 10.1002/(SICI)1097-0142(19991115)86:10<1936: :AID-CNCR9>3.0.CO;2-9 10570416
31. G. Galizia M. Orditura C. Romano E. Lieto P. Castellano L. Pelosio, et al. 2002 Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery Clin Immunol 102 169 178 10.1006/clim.2001.5163 1:CAS:528:DC%2BD38XisFWmtLk%3D 11846459 (Pubitemid 34171516)
32. L. Giacomelli W. Gianni C. Belfiore O. Gandini L. Repetto A. Filippini, et al. 2003 Persistence of epidermal growth factor receptor and interleukin 10 in blood of colorectal cancer patients after surgery identifies patients with high risk to relapse Clin Cancer Res 9 2678 2682 1:CAS:528:DC%2BD3sXlt1yrs7s%3D 12855647
33. F.Y. Yue R. Dummer R. Geertsen G. Hofbauer E. Laine S. Manolio, et al. 1997 Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules Int J Cancer 71 630 637 10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E 1:CAS:528:DyaK2sXjvFCnurY%3D 9178819 (Pubitemid 27239375)
34. J.E. Cortes M. Talpaz F. Cabanillas J.F. Seymour R. Kurzrock 1995 Serum levels of Interleukin-10 in patients with diffuse large cell lymphoma: Lack of correlation with prognosis Blood 85 2516 2520 1:CAS:528:DyaK2MXlt1OlsrY%3D 7537119
35. J. Sjoberg M. Aguilar-Santelises A.M. Sjogren E.K. Pisa A. Ljungdahl M. Bjorkholm, et al. 1996 Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease Br J Haematol 92 393 400 10.1046/j.1365-2141.1996.00358.x 1:STN:280: DyaK287ovFymsQ%3D%3D 8603006
36. S. Adris S. Klein M. Jasnis E. Chuluyan M. Ledda A. Bravo, et al. 1999 IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response Gene Ther 6 1705 1712 10.1038/sj.gt.3301012 1:CAS:528:DyaK1MXmslSmtrg%3D 10516719 (Pubitemid 29485945)
37. M. Giovarelli P. Musiani A. Modesti P. Dellabona G. Casorati A. Allione, et al. 1995 Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory J Immunol 155 3112 3123 1:CAS:528:DyaK2MXnvFCitLo%3D 7673726
38. G. Richter S. Kruger-Krasagakes G. Hein C. Huls E. Schmitt T. Diamantstein, et al. 1993 Interleukin-10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration Cancer Res 53 4134 4137 1:CAS:528:DyaK3sXmsVOrt7c%3D 8364905
39. C.M. Gerard C. Bruyns A. Delvaux N. Baudson J.L. Dargent M. Goldman, et al. 1996 Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells Hum Gene Ther 7 23 31 10.1089/hum.1996.7.1-23 1:CAS:528:DyaK28Xht1ahsbg%3D 8825865
40. G.A. Gastl J.S. Abrams D.M. Nanus R. Oosterkamp J. Silver F. Liu, et al. 1993 Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression Int J Cancer 55 96 101 10.1002/ijc.2910550118 1:CAS:528:DyaK2cXhs1Shsbc%3D 8344757
41. J.P. Herbeuval E. Lelievre C. Lambert M. Dy C. Genin 2004 Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6 J Immunol 172 4630 4636 1:CAS:528:DC%2BD2cXitlOqur8%3D 15034082
42. L.M. Zheng D.M. Ojcius F. Garaud C. Roth E. Maxwell Z. Li, et al. 1996 Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism J Exp Med 184 579 584 10.1084/jem.184.2.579 1:CAS:528:DyaK28XltVCrsL8%3D 8760811
43. R.M. Berman T. Suzuki H. Tahara P.D. Robbins S.K. Narula M.T. Lotze 1996 Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice J Immunol 157 231 238 1:CAS:528:DyaK28Xjslynsr0%3D 8683120
44. A. Jarry C. Bossard C. Bou-Hanna D. Masson E. Espaze M.G. Denis, et al. 2008 Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants J Clin Invest 118 1132 1142 1:CAS:528:DC%2BD1cXivFemsbw%3D 18259614
45. S. Huang S.E. Ullrich M. Bar-Eli 1999 Regulation of tumor growth and metastasis by interleukin-10:the melanoma experience J Interferon Cytokine Res 19 697 703 10.1089/107999099313532 1:CAS:528:DyaK1MXltFGgsLc%3D 10454339 (Pubitemid 29379811)
46. M.E. Stearns F.U. Garcia K. Fudge J. Rhim M. Wang 1999 Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice Clin Cancer Res 5 711 720 1:CAS:528:DyaK1MXitVyitrw%3D 10100726
47. L. Cervenak L. Morbidelli D. Donati S. Donnini T. Kambayashi J.L. Wilson, et al. 2000 Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10 Blood 96 2568 2573 1:CAS:528:DC%2BD3cXntVaqsrc%3D 11001913
48. N. Kundu R. Dorsey M.J. Jackson P. Guiterrez K. Wilson S. Fu, et al. 1998 Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide Int J Cancer 76 713 719 10.1002/(SICI)1097-0215(19980529)76:5<713:: AID-IJC17>3.0.CO;2-4 1:CAS:528:DyaK1cXjsFeku7o%3D 9610731 (Pubitemid 28243946)